NSTI Announces More Than 50 Early Stage Company Reviews at Nanotech Ventures 2005 - Top Corporate and Private VC Firms Lead Vetting Teams

Share Article

The Nano Science and Technology Institute (NSTI) today announced its Nanotech Ventures 2005 Conference to be held in Anaheim at the Anaheim Marriott Conference Center will exceed 50 early stage nanotech companies presenting at its annual Early Stage Review.

Small technologies are rapidly maturing from lab to marketplace. The Nanotech Ventures 2005 Early Stage Company Review provides an ideal forum for "seed" to "early-stage" companies to showcase their technologies, market advantages, and to search for funding. Companies are given 15 minutes to present and will have on-site feedback from Nanotech Ventures Vetting Team. This years team includes representatives from such firms as: IBM, Intel Capital, Mohr, Davidow Ventures, Burns Doane, DuPont Ventures, ChevronTexaco Technology Ventures, Motorola Investments, Echelon Ventures, Echelon Ventures, Wilmer Cutler Pickering Hale and Dorr, Harris and Harris Group, Greenberg Traurig, 3i, UBS and Draper Fisher Jurvetson.

The goal of the Early Stage event is to unite early stage public and pre-IPO small-technology products and intellectual property (IP) with industrial users, funding sources, technology providers and the media and analysts community. This venue will be used to promote the commercial maturation across the nanotechnology landscape, globally from technology to products.

The format is a fast-paced event consisting of a 15-minute briefing covering the products, target customers and business/licensing model for the presenting company. This will be followed by a short review from members of the panel including Q & A. Further one-on-one networking and business development discussions are held in preset meeting areas.

Presenting companies are clustered by focus and include: Healthcare with Inovatia Lab., Alpha-O Peptides, 3DM Inc., AptaSense, and Nano Interface Technology, Inc., presenting; Biotech featuring Biophan Technologies, Inc., Cambridge Biomagnetics, CytImmune Sciences, Inc., Midatech Limited, Nano S Biotechnologie, NanoBioMagnetics, Inc., NanoTechLogic Corporation, Nanotrope, Inc., Raustech Pty.Ltd., Russian Biotechnologies and ViaLogy Corp.: Electronics will have Arccure technologies, Nanometrix, Inc., NanoOpto Corporation, Nanopower Technologies, Inc., Optimer Photonics, Inc. and XCom Wireless, Inc.; Materials includes presentations by Advanced Diamond Technologies, Inc., Applied MicroStructures, Atomistix A/S, Ceimig Ltd, ENSbio, Nanothinx and Solaris Nanosciences; Energy features Akermin, Blu-Si, Collossus Nanotech and QuantumSphere; Sensors has Applied Standard, BioNano Systems, Cantion A/S, CENTICE Corp., MET Tech and SENSIA presenting; Instrumentation features Digital Matrix Corp, Focal Point Microsystems, Iatia Ltd, Ionscope Limited, Molecular Imprints, Prodyne Corp. and Quantum Precision Instruments.

Nanotech Ventures runs concurrently with Nanotech 2005, now celebrating its 8th year, is the world’s largest nanotechnology conference of its kind. The three-day conference provides over 60 sessions on business and finance related to nanotechnology. The event also profiles new companies and technologies and encourage business and scientific discussion among nanotech and financial industry leaders.

To register for Nanotech Ventures or learn more information, go to http://www.nsti.org/NanotechVentures2005/. For additional information on sponsorship or exhibiting, please call (203)245-4201. Media please contact Miranda Tan at 212-941-8499 or mtan@excitepr.com

About NSTI

The NSTI provides analysis and information services for government, business and industrial clients worldwide. The NSTI staff and vast network of science advisors provide confidential technology and product review services covering all domains of nano, bio, and micro technologies. For more information, please contact info@nsti.org.

# # #

Share article on social media or email:

View article via:

Pdf Print